However, another study showed that METTL3 upregulates FGD5-AS1 expression through m6A modification, enhances chemoresistance in endometrial cancer cells, and promotes immune escape (Hao et al., 2024[73]). This evidence concerns the gene METTL3 and endometrial cancer.